Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis

Cancer Research

Volumn 70, Issue 5, 2010, Pages 1835-1844

  Ooi, Li Laine ^a   Zhou, Hong ^a   Kalak, Robert ^a   Zheng, Yu ^a   Conigrave, Arthur D ^a   Seibel, Markus J ^a   Dunstan, Colin R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPROTEGERIN; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE GROWTH; BONE LESION; BONE METASTASIS; BONE RADIOGRAPHY; BONE TURNOVER; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MDA MB 231; CONTROLLED STUDY; DIET; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOLYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; TUMOR GROWTH; VITAMIN D DEFICIENCY;

ANIMALS; BONE NEOPLASMS; BONE RESORPTION; BREAST NEOPLASMS; CALCIFEDIOL; CALCITRIOL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; OSTEOPROTEGERIN; STEROID HYDROXYLASES; TRANSPLANTATION, HETEROLOGOUS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77950284096     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-3194     Document Type: Article

References (40)

1. Garland CF, Garland FC, Gorham ED, et al. The role of Vitamin D in cancer prevention. Am J Public Health 2006;96:252-261
2. Grant WB, Mohr SB. Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann Epidemiol 2009;19:446-454
3. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080-6S.
4. Grant WB. Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates. J Natl Med Assoc 2006;98:357-364
5. Giovannucci EL. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005;16:83-95.
6. Abbas S, Linseisen J, Slanger T, et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer-results of a large case-control study. Carcinogenesis 2008;29:93-99
7. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 2009;27:3757-3763
8. Matsumoto K, Azuma Y, Kiyoki M, Okumura H, Hasimoto K, Yoshikawa K. Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes. Biochim Biophys Acta 1991;1092:311-318
9. Peng X, Hawthorne M, Vaishnav A, St-Arnaud R, Mehta RG. 25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ culture. Breast Cancer Res Treat 2009;113:31-41.
10. Townsend K, Banwell CM, Guy M, et al. Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res 2005;11:3579-3586
11. Cross HS, Lipkin M, Kallay E. Nutrients regulate the colonic vitamin D system in mice: relevance for human colon malignancy. J Nutr 2006;136:561-564
12. Pendas-Franco N, Gonzalez-Sancho JM, Suarez Y, et al. Vitamin D regulates the phenotype of human breast cancer cells. Differentiation 2007;75:193-207.
13. 3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells. Endocrinology 2009;150:2046-2054
14. Pendas-Franco N, Aguilera O, Pereira F, Gonzalez-Sancho JM, Munoz A. Vitamin D and Wnt/β-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Res 2008;28:2613-2623
15. Zheng Y, Zhou H, Modzelewski JRK, et al. Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumour growth in bone. Cancer Res 2007;67:9542-9548
16. Zheng Y, Zhou H, Brennan K, et al. Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis. Bone 2006;40:471-478
17. Siclari VA, Guise TA, Chirgwin JM. Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases. Cancer Metastasis Rev 2006;25:621-633
18. Chiang AC, Massague J. Molecular basis of metastasis. N Eng J Med 2008;359:2814-2823
19. Goltzman D, White J, Kremer R. Studies of the effects of 1,25-dihydroxyvitamin D on skeletal and calcium homeostasis and on inhibition of tumour cell growth. J Ster Biochem Mol Biol 2001;76:43-47.
20. Jesudason D, Need AG, Horowitz M, O'Loughlin PD, Morris HA, Nordin BEC. Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency. Bone 2002;31:626-630
21. Mihai R. The calcium sensing receptor: from understanding parathyroid calcium homeostasis to bone metastases. Ann R Coll Surg Engl 2008;90:271-277
22. Peterlik M, Cross HS. Cross, vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 2005;35:290-304.
23. Mundy G. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2:584-593
24. Guise TA. Molecular mechanisms of osteolytic bone metastasis. Cancer 2000;88:2892-2898
25. Need AG. Bone resorption markers in vitamin D insufficiency. Clin Chim Acta 2006;368:48-52.
26. Anderson PH, Sawyer RK, May BK, O'Loughlin PD, Morris HA. 25-Hydroxyvitamin D requirement for maintaining skeletal health utilising a Sprague-Dawley rat model. J Ster Biochem Mol Biol 2007;103:592-595
27. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-319
28. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 2001;16:1486-1495
29. Bult P, Manders P, Straatman HMPM, et al. In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-up. Breast Cancer Res Treat. Epub 2009 Sep 17.
30. Ladekarl M. Choice of methodology for quantifying cancer structures in tissue sections. A comparison of 2- and 3-dimensional estimators of mitotic activity, cellularity and nuclear size in breast cancer. Anal Quant Cytol Histol 2004;26:97-104.
31. Mehta RR, Graves JM, Hart GD, Shilkaitis A, Das Gupta TK. Growth and metastasis of human breast carcinomas with Matrigel in athymic mice. Breast Cancer Res Treat 1993;25:65-71.
32. Morris HA. Vitamin D: a hormone for all seasons-how much is enough? Understanding the new pressures. Clin Biochem Rev 2005;25:21-32.
33. Vieth R, Chan PCR, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001;73:288-294
34. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006;116:2062-2072
35. Holick MF. Vitamin D deficiency. N Eng J Med 2007;357:266-281
36. Kornfehl J, Formanek M, Temmel A, Knerer B, Willheim M. Antiproliferative effects of the biologically active metabolite of vitamin D3 (1,25[OH]2D3) on head and neck squamous cell carcinoma cell lines. Eur Arch Otorhinolaryngol 1996;253:341-344
37. Colston KW, Mork Hansen C. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 2001;9:45-49
38. Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: global perspective. Ann Epidemiol 2009;19:468-483
39. Lipkin M, Newmark HL. Vitamin D, calcium and prevention of breast cancer: a review. J Am Coll Nutr 1999;18:392-397
40. Need AG, Christopher Nordin BE. Misconceptions-vitamin D insufficiency causes malabsorption of calcium. Bone 2008;42:1021-1024